Percutaneous treatment of mitral valve disease

Authors

  • Dr. Igor F. Palacios Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Abstract

Mitral valve disease is one of the most commonvalvular heart conditions. A true incidence ofmitral valve disease is unknown (1,2). Theprevalence of rheumatic disease in developedcountries is declining with an estimated incidenceof 1 in 100 000.

Downloads

Download data is not yet available.

Downloads

How to Cite

Palacios, D. I. F. (2020). Percutaneous treatment of mitral valve disease. Gaceta Médica De Caracas, 126(4), 345–362. Retrieved from https://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/17315

Issue

Vol. 126 No. 4 (2018)

Section

ESTADO DEL ARTE